Qun Zhou

Person

Ashland, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Site-specific antibody-drug conjugation through glycoengineering
- Patent number 12,110,338
- Issue date Oct 8, 2024
- Genzyme Corporation
- Clark Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified binding polypeptides for optimized drug conjugation
- Patent number 11,879,004
- Issue date Jan 23, 2024
- Genzyme Corporation
- Qun Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site-specific glycoengineering of targeting moieties
- Patent number 11,697,690
- Issue date Jul 11, 2023
- Genzyme Corporation
- Luis Avila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligosaccharide-protein conjugates
- Patent number 11,279,725
- Issue date Mar 22, 2022
- Genzyme Corporation
- Luis Z. Avila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glycoengineered antibody drug conjugates
- Patent number 11,160,874
- Issue date Nov 2, 2021
- Genzyme Corporation
- Luis Z. Avila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site-specific antibody-drug conjugation through glycoengineering
- Patent number 11,130,816
- Issue date Sep 28, 2021
- Genzyme Corporation
- Clark Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site-specific glycoengineering of targeting moieties
- Patent number 10,995,148
- Issue date May 4, 2021
- Genzyme Corporation
- Luis Avila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligosaccharide-protein conjugates
- Patent number 10,464,962
- Issue date Nov 5, 2019
- Genzyme Corporation
- Luis Z. Avila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Site-specific antibody-drug conjugation through glycoengineering
- Patent number 10,214,589
- Issue date Feb 26, 2019
- Genzyme Corporation
- Clark Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycoengineered antibody drug conjugates
- Patent number 10,064,952
- Issue date Sep 4, 2018
- Genzyme Corporation
- Luis Z. Avila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Site-specific antibody-drug conjugation through glycoengineering
- Patent number 9,580,511
- Issue date Feb 28, 2017
- Genzyme Corporation
- Clark Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligosaccharide-protein conjugates
- Patent number 9,493,498
- Issue date Nov 15, 2016
- Genzyme Corporation
- Luis Z. Avila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligosaccharide-protein conjugates
- Patent number 8,835,614
- Issue date Sep 16, 2014
- Genzyme Corporation
- Luis Z. Avila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-based therapeutics with enhanced ADCC activity
- Patent number 8,071,336
- Issue date Dec 6, 2011
- Genzyme Corporation
- John M. McPherson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody-based therapeutics with enhanced ADCC activity
- Patent number 7,700,321
- Issue date Apr 20, 2010
- Genzyme Corporation
- John M. McPherson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION
- Publication number 20240218051
- Publication date Jul 4, 2024
- Genzyme Corporation
- Qun Zhou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNC...
- Publication number 20240166750
- Publication date May 23, 2024
- Ablynx N.V.
- Julie A. Jaworski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES
- Publication number 20240117071
- Publication date Apr 11, 2024
- Genzyme Corporation
- Luis AVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES
- Publication number 20240059793
- Publication date Feb 22, 2024
- Genzyme Corporation
- Luis AVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION
- Publication number 20230391849
- Publication date Dec 7, 2023
- Genzyme Corporation
- Qun Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGOSACCHARIDE-PROTEIN CONJUGATES
- Publication number 20220242899
- Publication date Aug 4, 2022
- Genzyme Corporation
- Luis Z. AVILA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES
- Publication number 20220119547
- Publication date Apr 21, 2022
- Genzyme Corporation
- Luis AVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYCOENGINEERED ANTIBODY DRUG CONJUGATES
- Publication number 20220088214
- Publication date Mar 24, 2022
- Genzyme Corporation
- Luis Z. Avila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING
- Publication number 20220089763
- Publication date Mar 24, 2022
- Genzyme Corporation
- Clark PAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION
- Publication number 20210292391
- Publication date Sep 23, 2021
- Genzyme Corporation
- Qun Zhou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLIGOSACCHARIDE-PROTEIN CONJUGATES
- Publication number 20200216485
- Publication date Jul 9, 2020
- Genzyme Corporation
- Luis Z. AVILA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING
- Publication number 20190233531
- Publication date Aug 1, 2019
- Genzyme Corporation
- Clark PAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYCOENGINEERED ANTIBODY DRUG CONJUGATES
- Publication number 20190060481
- Publication date Feb 28, 2019
- Genzyme Corporation
- Luis Z. Avila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLIGOSACCHARIDE-PROTEIN CONJUGATES
- Publication number 20180002365
- Publication date Jan 4, 2018
- Genzyme Corporation
- Luis Z. AVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING
- Publication number 20170267774
- Publication date Sep 21, 2017
- Genzyme Corporation
- Clark PAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYCOENGINEERED ANTIBODY DRUG CONJUGATES
- Publication number 20160136299
- Publication date May 19, 2016
- Genzyme Corporation
- Luis Z. Avila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES
- Publication number 20160060354
- Publication date Mar 3, 2016
- Genzyme Corporation
- Luis AVILA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGOSACCHARIDE-PROTEIN CONJUGATES
- Publication number 20150175643
- Publication date Jun 25, 2015
- Genzyme Corporation
- Luis Z. Avila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING
- Publication number 20140294867
- Publication date Oct 2, 2014
- Genzyme Corporation
- Clark PAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGOSACCHARIDE-PROTEIN CONJUGATES
- Publication number 20110300120
- Publication date Dec 8, 2011
- Luis Z. Avila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY
- Publication number 20100184145
- Publication date Jul 22, 2010
- Genzyme Corporation
- John M. McPherson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY
- Publication number 20070092521
- Publication date Apr 26, 2007
- John M. McPherson
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Site-specific antibody-drug conjugation through glycoengineering

Modified binding polypeptides for optimized drug conjugation

Site-specific glycoengineering of targeting moieties

Oligosaccharide-protein conjugates

Glycoengineered antibody drug conjugates

Site-specific antibody-drug conjugation through glycoengineering

Site-specific glycoengineering of targeting moieties

Oligosaccharide-protein conjugates

Site-specific antibody-drug conjugation through glycoengineering

Glycoengineered antibody drug conjugates

Site-specific antibody-drug conjugation through glycoengineering

Oligosaccharide-protein conjugates

Oligosaccharide-protein conjugates

Antibody-based therapeutics with enhanced ADCC activity

Antibody-based therapeutics with enhanced ADCC activity

Patents Applicationslast 30 patents

MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION

GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNC...

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION

OLIGOSACCHARIDE-PROTEIN CONJUGATES

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

GLYCOENGINEERED ANTIBODY DRUG CONJUGATES

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING

MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION

OLIGOSACCHARIDE-PROTEIN CONJUGATES

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING

GLYCOENGINEERED ANTIBODY DRUG CONJUGATES

OLIGOSACCHARIDE-PROTEIN CONJUGATES

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING

GLYCOENGINEERED ANTIBODY DRUG CONJUGATES

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

OLIGOSACCHARIDE-PROTEIN CONJUGATES

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING

OLIGOSACCHARIDE-PROTEIN CONJUGATES

ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY

ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY